Molecular Partners Ag (NASDAQ:MOLN) appeared in the 13F filings of 5 institutional investors for the quarter ended June 30, 2026.
Their combined stake equaled 9.64% of outstanding shares in Q2 2026, unchanged from 9.64% in Q1 2026.
Total holdings of MOLN shares rose 0.05% from Q1 2026, and the holder count fell 16.67% from Q2 2025.
Among the 5 holders of Molecular Partners Ag, 2 added to their positions and 3 left their positions unchanged.
In total, institutional investors held 3.59Mn shares of Molecular Partners Ag at the end of Q2 2026, up 1.92K from the prior quarter and down 3.92K from a year earlier.
As of June 30, 2026, the biggest holder of Molecular Partners Ag was Montanova Capital, LLC with 2.22Mn shares, or 5.96% of shares outstanding.
Molecular Partners Ag's 5 largest institutional shareholders as of Q2 2026 were Montanova Capital, LLC (2.22Mn shares), BVF Inc (1.35Mn shares), Citadel Advisors LLC (17.18K shares), Morgan Stanley (367 shares) and UBS Group AG (279 shares), per Business Quant data.